RPL21P104

Across TCGA pan-cancer cohorts, RPL21P104 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL21P104’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPL21P104 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL21P104 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

LUAD and KIRC are the cancer types where RPL21P104 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL21P104 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.066	.018	2	view →
KIRC	Male	All	−0.015	.027	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL21P104–LUAD

Open the LUAD breakdown →